• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Biogen Inc. (BIIB)

    274.99 Apr 29, 4:00PM EDT
    |Pre-Market : 274.99 0.00 (0.00%) 8:05AM EDT - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:345.67
    Median Target:347.50
    High Target:450.00
    Low Target:268.00
    No. of Brokers:18

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 25, 2016CitigroupInitiated Buy
    Jan 20, 2016Credit SuisseInitiated Neutral
    Jan 7, 2016Standpoint ResearchInitiated Buy
    Sep 9, 2015JefferiesInitiated Buy
    Sep 1, 2015Raymond JamesInitiated Strong Buy
    Aug 11, 2015H.C. WainwrightInitiated Buy
    Jul 27, 2015Robert W. BairdDowngradeOutperformNeutral
    Jul 27, 2015BernsteinUpgradeMkt PerformOutperform
    Jul 24, 2015BMO Capital MarketsDowngradeOutperformMarket Perform
    Jul 22, 2015Piper JaffrayDowngradeOverweightNeutral

    More Upgrades & Downgrades for BIIB

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy7767

    Data provided by Thomson/First Call

    Currency in USD.